Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Abstract Background In multiple sclerosis, coagulation factors have been shown to modulate inflammation. In this translational study, we investigated whether long-term anticoagulation with warfarin or rivaroxaban has beneficial effects on the course of autoimmune experimental encephalomyelitis (EAE)...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Leonie Stolz, Amin Derouiche, Kavi Devraj, Frank Weber, Robert Brunkhorst, Christian Foerch
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2017-07-01
Sarja:Journal of Neuroinflammation
Aiheet:
Linkit:http://link.springer.com/article/10.1186/s12974-017-0926-2